Please enable Javascript to use all features and improve your user experience.
ECV 2023
Programme
People
Search
DE
Back
Poster session
Poster session 1
SARS-CoV-2 and other coronaviruses
Appointment
Date:
5th May 2023
Time:
07:00 p.m.
–
08:30 p.m.
Location / Stream:
SARS -CoV2 and other coronaviruses
Programme
Poster Presentation
PP 073
Paper-based microfluidic device for rapid and on-site virus detection
Dr. Zhugen Yang (Milton Keynes / GB)
SARS -CoV2 and other coronaviruses
Poster Presentation
PP 074
A paper sensor for viral RNA and protein detection for SARS-CoV-2 in saliva
Dr. Zhugen Yang (Milton Keynes / GB)
SARS -CoV2 and other coronaviruses
Poster Presentation
PP 075
Retrospective screening of SARS-CoV-2 antibodies in cerebrospinal fluid samples of patients with neurological manifestations of unknown aetiology in a tertiary care hospital during the pandemic period
Dr. Amrita Pattanaik (Udupi / IN)
SARS -CoV2 and other coronaviruses
Poster Presentation
PP 076
Adaptive immune response to different combinations of SARS-CoV-2 vaccination and breakthrough infection
Dr. Jernej Pusnik (Bonn / DE)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 077
Development of a high-throughput neutralization assay for SARS-CoV-2 and its application in the assessment of the antibody response in a cohort of vaccinated pregnant women
Gabriela Mattoso Coelho (Curitiba / BR)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 078
Understanding SARS-CoV-2 transmission, infection and susceptibility in neovison vison
Vinaya Venkat (Helsinki / FI)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 079
SARS-CoV-2 inhibiting antibodies were discovered in the sera of one leopard and two rhinoceros during serosurveillance on Dvůr Králové Zoo animals
Dr. Jignesh Italiya (Prague / CZ)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 080
Epidemiological and pathophysiological assessment of Coronavirus disease (COVID-19) patients – a retrospective study
Dr. Niamatullah Kakar (Turbat / PK)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 081
SARS-CoV-2 infection landscape and antiviral drug effects in airway multiciliated epithelium derived from iPSC
Lisa Morichon (Montpellier / FR)
Antivirals, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 082
Impact of Ace2 and Tmprss2 polymorphisms on Covid-19 severity in a subset of Pakistani population
Dr. Santosh Kumar Sidhwani (Karachi / PK)
SARS -CoV2 and other coronaviruses
Poster Presentation
PP 083
Proteomic analysis of human non-small cell lung carcinoma (LC-HK2) infected with SARS-COV2
Dr. Thatiana Melo (São Paulo / BR)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 084
Proteomic analysis of THP1-derived macrophages infected with SARS-CoV-2
Dr. Hellen Valerio (São Paulo / BR)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 085
Cytokine deficiencies in persons with Long-COVID
Professor Vicente Planelles (Salt Lake City, UT / US)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 086
In Vivo models for evaluating a pharmaceutical drug against SARS-CoV-2
Chiho Yu (Daejeon / KR)
SARS -CoV2 and other coronaviruses
Poster Presentation
PP 087
Stepping up in immunomonitoring – EliSpot five colour cytokine release assay
Rosemarie Preyer (Strassberg / DE)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 089
Humoral responses following SARS-CoV-2 vaccination with homologous doses of CoronaVac, ChAdOx1 or BTN162B2 in people living with HIV
Susann Hohensee (Luebeck / DE)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 095
Relevance of SARS-CoV-2 accessory genes to virulence in a transgenic mouse model of infection
Jesus Hurtado-Tamayo (Madrid / ES)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 096
Novel CRISPR-Cas13d system to target highly conserved sequences of SARS-CoV-2 and other human coronaviruses
Mouraya Hussein (Amsterdam / NL)
Antivirals, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 097
Development of an automated assay for the quantitative detection of neutralizing antibodies against SARS-CoV-2
Fabien Fulmar (Marcy l'Etoile / FR)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 098
Meta-analysis of genome-wide CRISPR screens reveals RAB9A as a SARS-CoV-2 entry factor
Yannick Stahl (Heidelberg / DE)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 099
Identification of new B cell epitopes in the stem helix region in S2 domain of the Spike protein with different degrees of conservation among human and animal beta-coronavirus
Dr. Kah Man Lai (Singapore / SG)
SARS -CoV2 and other coronaviruses
Poster Presentation
PP 100
Validation of the K18-hACE2 humanized mouse model of SARS-CoV-2 for preclinical screening of antiviral therapeutics
Dr. Yvette Kazungu (Liverpool / GB)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 101
Memory T-cell epitope-based peptide vaccine candidates against Middle East Respiratory Syndrome Coronavirus
Dr. Hyun-Joo Kim (Cheongju-si / KR)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 102
Small interfering RNA effectively inhibit the SARS-CoV-2 infection
Dr. Se Hun Gu (Daejeon / KR)
SARS -CoV2 and other coronaviruses
Poster Presentation
PP 103
Structural and functional mechanism of SARS-CoV-2 cell entry
Tea Govednik (Ljubljana / SI)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 104
Antioxidant compounds inhibit SARS-CoV-2 cell entry and mitigate inflammation
Tea Govednik (Ljubljana / SI)
Antivirals, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 105
Comparison of biological and biochemical neutralization tests to detect neutralizing antibodies to SARS-CoV-2
Sari Maljanen (Turku / FI)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 106
Seasonal coronavirus infection and reinfection rates in early childhood in Southwest Finland
Pekka Kolehmainen (Turku / FI)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 107
Emergency preparedness and integrated surveillance potential of a rapid COVID-19 diagnostic for airport quarantine in Bangladesh
Dr. Muhammad Asaduzzaman (Oslo / NO)
One Health, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 108
Direct lysis RT-qPCR-based RNAi screen of SARS-CoV-2 production reveals host genes involved in the entire replication cycle
Alison Daniels (Edinburgh / GB)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 109
RNA-based regulation of the interferon immune response during SARS-CoV-2 infection
Marco Antonio Olguin Nava (Wuerzburg / DE)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 110
Mapping the viral entry platforms in 3D tissue cultures
Dr. Katarzyna Owczarek (Cracow / PL)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 111
High prevalence of undocumented SARS-CoV-2 infections in the pediatric population of the tyrolean district of Schwaz
Dr. Barbara Falkensammer (Innsbruck / AT)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 112
Evaluation of in-vitro and in-vivo antiviral activities of vitamin D for SARS CoV-2 and variants
Dr. Yan Ling Ng (Singapore / SG)
Antivirals, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 113
Pre-existing titers of neutralizing antibodies determine the risk of SARS-CoV-2 Omicron breakthrough infections
Catharina Christa (Munich / DE)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 114
Molecular docking study
of
Beta amyrin from mangrove against SARS-CoV-2 proteins
R. Purushothaman (Chidambaram / IN)
Antivirals, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 116
Detection of SARS-CoV-2 variants by different diagnostics assays
Dr. Anna Rosa Garbuglia (Rome / IT)
One Health, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 117
Investigating the role of stress granules in virus infection
Reto Lang (Bern / CH)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 118
The evolving network of associated SARS-CoV-2 spike variable positions – from cliques and communities to constellations of key substitutions in emerging variants
Dr. Cleo Anastassopoulou (Athens / GR)
SARS -CoV2 and other coronaviruses
Poster Presentation
PP 119
A novel 3CLpro luciferase reporter assay allowing the identification of coronavirus protease inhibitors
Dr. Dorota Kmiec (Ulm / DE)
Antivirals, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 120
Baseline plasma SARS-CoV-2 RNA viral load predicts an adverse COVID-19 evolution in hospitalized patients with moderate to severe disease
Dr. Paolo Ravanini (Novara / IT)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 121
BA.1, BA.2 and BA.2.75 variants show comparable replication kinetics, reduced impact on epithelial barrier and elicit cross-neutralizing antibodies
Professor Guruprasad Medigeshi (Faridabad / IN)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 122
Effectiveness of ceiling-mounted ultraviolet lamps – an experimental study
Jeong Young Lee (Seoul / KR)
SARS -CoV2 and other coronaviruses
Poster Presentation
PP 123
Usefulness of the rapid antigen test in detecting severe acute respiratory syndrome coronavirus 2 for infection control in hospitals
Jeong Young Lee (Seoul / KR)
SARS -CoV2 and other coronaviruses
Poster Presentation
PP 124
Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes
Dr. Rayhane Nchioua (Ulm / DE)
Antivirals, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 125
Molecular analyses of clinical isolates and recombinant SARS-CoV-2 carrying B.1 and B.1.617.2 spike mutations suggest a potential role of non-spike mutations in infection kinetics
Maximilian A. Kelch (Frankfurt / DE)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 126
Investigation of the entry pathways of SARS-CoV-2 by using fluorescence-labelling SARS-CoV-2 Virus-like particles
Dr. Li-Wei Chu (Taipei City / TW)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 127
The roles of CCR5 in SARS-CoV-2 infection
Dr. Po-Ru Chen (Taipei City / TW)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 128
Genetic epidemiology of SARS-CoV-2 (hCoV-19) in Southern Poland
Professor Tomasz Wąsik (Sosnowiec / PL)
SARS -CoV2 and other coronaviruses
Poster Presentation
PP 129
Individuals with Long COVID – sustained immune alterations after a 6-month period
Clara Sánchez-Menéndez (Majadahonda / ES)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 130
The 'true' scale of COVID-19 pandemic – the longitudinal quantitative and qualitative analysis on the SARS-CoV-2 in the wastewater in Poznan, Poland
Dr. Pawel Zmora (Poznan / PL)
One Health, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 131
Distinctly lower sensitivity of Golden Syrian hamsters to SARS-CoV-2 Omicron BA.2 as compared to the ancestral strain 2019_nCoV Muc-IMB-1
Dr. Anne Balkema-Buschmann (Greifswald – Insel Riems / DE)
One Health, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 132
An RNA replicon system to investigate promising inhibitors of feline infectious peritonitis Coronavirus
Kimberly S. Schmied (Bern / CH)
Antivirals, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 133
High levels of soluble endothelial cell protein C receptor in plasma of individuals with Long-COVID proves the role of endothelial dysfunction in the persistence of COVID-19
Alicia Simón-Rueda (Majadahonda / ES)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 134
RIG-I-like receptor gene polymorphisms in patients hospitalized due to COVID-19
Dariusz Jarych (Lodz / PL)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 135
Frequency of TLR3, 7 and 8 gene polymorphisms in patients with moderate and severe COVID-19
Professor Edyta Paradowska (Lodz / PL)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 136
Cellular translation and splicing associated factors cleaved by the coronavirus proteases
Professor Guigen Zhang (Guangzhou / CN)
Antivirals, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 137
Assessment of circulation of SARS-COV-2 and other coronaviruses in dogs and cats in Italy
Dr. Donato Raele (Foggia / IT)
Dr. Nicola Cavaliere (Foggia / IT)
One Health, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 138
Generation of SARS-CoV-2 variants from RNA using a combined ARTIC-TAR system
Dr. Bettina S. Trüeb (Bern / CH)
SARS -CoV2 and other coronaviruses
Poster Presentation
PP 139
Whole virion purification of SARS-CoV-2 for immunological studies
Balazs Antal Somogyi (Pécs / HU)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 140
Novel molecular targets – structural evaluation of the SARS-CoV-2 M
pro
oligomerization
Kinga Lis (Cracow / PL)
Antivirals, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 141
Cytokine profiles in patients with mild and severe COVID-19
Professor Edyta Paradowska (Lodz / PL)
Dariusz Jarych (Lodz / PL)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 142
Development of a flow cytometry-based micro-neutralisation assay to elavuate humoral immunity against SARS-COV-2 variants of concern in vaccine trials
Sophie O'Reilly (Dublin / IE)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 143
Fragment screening against the SARS-CoV-2 macrodomain
Dr. Frank Lennartz (Berlin / DE)
Antivirals, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 144
The SUMO pathway targets SARS-CoV-2 replication and is a potential target for antiviral development
Leah Ennis McLoughlin (Dublin / IE)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 145
SARS-CoV-2 hijacks the host mRNA m6Am cap methylase to sustain viral replication
Dr. Nadine Ebert (Bern / CH)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 146
Problem of normalisation the concentration of SARS-CoV-2 RNA in wastewater samples on example every week analysis of samples collected in Czajka, Warsaw, Poland
Prof. Dr. Katarzyna Pancer (Warsaw / PL)
One Health, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 147
SARS-CoV-2 detection in aircraft wastewater – a new challenge
Klaudia Ordyniak (Warsaw / PL)
Prof. Dr. Katarzyna Pancer (Warsaw / PL)
One Health, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 148
SARS-CoV-2 cell entry, infection and host targeting antivirals
Ravi Ojha (Helsinki / FI)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 149
The role of membrane complexity in the early entry stages of SARS-CoV-2 variants
Dario Conca (Umeå / SE)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 150
Genomic stability evaluation of SARS-CoV-2 lineages suggests higher evolutionary rate of the early strains
Dr. Gediminas Alzbutas (Kaunas / LT)
SARS -CoV2 and other coronaviruses, Virus-host interactions: entry, replication, assembly, egress
Poster Presentation
PP 151
Hyaluronan is a key player in COVID-19 pathogenesis – mechanisms and treatments
Professor Annasara Lenman (Umeå / SE)
SARS -CoV2 and other coronaviruses
Poster Presentation
PP 152
Establishment of a nose-only individual aerosolization device for infection and drug efficacy studies in small animals
Dr. Anne Balkema-Buschmann (Greifswald – Insel Riems / DE)
Antivirals, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 153
The efficacy of SARS-CoV-2- specific IgY antibodies in infected hamsters
Dr. Mónika Madai (Pécs / HU)
Antivirals, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 154
Structural and functional characterization of a novel monoclonal antibody with pan-neutralizing SARS-CoV-2 activity including BQ.1.1 variant
Andrea Modrego (Madrid / ES)
SARS -CoV2 and other coronaviruses
Poster Presentation
PP 155
The role of TLR9 signalling in the course of Covid-19
Professor Paulina Niedźwiedzka-Rystwej (Szczecin / PL)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 156
Longitudinal study of CD4+ T cells polarization in individuals with Long-COVID shows a persistent increase in pro-inflammatory populations and a decrease in antiviral response
Olivia de la Calle-Jiménez (Madrid / ES)
Immune response to virus infection, SARS -CoV2 and other coronaviruses
Poster Presentation
PP 157
Comparison of entry process of SARS-CoV2 variants into different types of cells
Mikołaj Piotrkowski (Gdansk / PL)
SARS -CoV2 and other coronaviruses, Virus and cancer
Poster Presentation
PP 158
The impact of insularity on SARS-CoV-2 diffusion – genetic snapshot of two years of COVID-19 pandemic in Sardinia
Dr. Nicole Grandi (Cagliari / IT)
SARS -CoV2 and other coronaviruses
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy